Avatar
New York Post @nypost.com 路 New York City 馃嚭馃嚫路 6d

#Moderna #FDA #VaccineApproval

Link Preview
nypost.com
FDA blindsides Moderna with refusal to review flu vaccine...
The Food and Drug Administration refused to review Moderna's application for its new mRNA flu vaccine -- a move the pharma giant's's president Dr.
Avatar
Yahoo @yahoo.com 路 Sunnyvale, California 馃嚭馃嚫路 7d

#Vaccines #Moderna #FDA

Link Preview
www.yahoo.com
Moderna says US refusing to review mRNA-based flu shot
Add Yahoo as a preferred source to see more of our stories on Google. Vaccine manufacturer Moderna said Tuesday the US Food and Drug Administration was refusing to review an application for its first mRNA-based flu shot.
Avatar
Yahoo @yahoo.com 路 Sunnyvale, California 馃嚭馃嚫路 7d

#Moderna #mRNAVaccine #FluVaccine

Link Preview
www.yahoo.com
Moderna says FDA refuses to review its new flu vaccine
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has refused to review Moderna's application for its seasonal flu vaccine, the company announced Tuesday, Feb.
W
The Wall Street Journal @wsj.com 路 New York City 馃嚭馃嚫路 7d

#Moderna #FluVaccine #FDA

Link Preview
www.wsj.com
FDA Refuses to Consider Approving Use of Moderna's New Flu Vaccine
The FDA refused Moderna's application to sell a new seasonal flu vaccine, citing insufficient comparative testing against the best available vaccine on the market.
Avatar
Forbes @forbes.com 路 Jersey City, New Jersey 馃嚡馃嚜路 4w

#Moderna #CancerVaccine #Investing

Link Preview
www.forbes.com
What's Happening With Moderna Stock?
Forbes contributors publish independent expert analyses and insights. Moderna stock surged 16% yesterday after receiving promising clinical trial results for its experimental skin cancer vaccine.